Form 4: Century Therapeutics' Chief Operations Officer Sells Shares to Cover Tax Obligations

Adrienne Farid, Chief Operations Officer of Century Therapeutics, sold 1,073 shares of common stock on August 5, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On August 5, 2024, Adrienne Farid, the Chief Operations Officer of Century Therapeutics, Inc. (IPSC), sold 1,073 shares of common stock.
• The sale was executed at a price of $1.827 per share.
• The transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Farid directly owns 136,163 shares of Century Therapeutics.
• The sale was automatic and not at the discretion of the reporting person.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sale of shares to cover taxes). It doesn't indicate positive or negative sentiment.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and are generally viewed as routine transactions.

Stakeholder Impact

• The sale of shares by an officer could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates